92 related articles for article (PubMed ID: 10442718)
41. Carcinoembryonic antigen and alpha-fetoprotein expression and monoclonal antibody targeting in a human hepatoma/nude mouse model.
Wang ZF; Stein R; Sharkey RM; Goldenberg DM
Cancer Res; 1990 Feb; 50(3 Suppl):869s-872s. PubMed ID: 1688735
[TBL] [Abstract][Full Text] [Related]
42. [Radioimmunoimaging of nude mice bearing human lung adenocarcinoma xenografts after injecting 131I-McAbs].
Liu L
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Oct; 13(5):363-6. PubMed ID: 1839256
[TBL] [Abstract][Full Text] [Related]
43. Diagnostic accuracy and tumor-targeting kinetics of complete versus fragmented 99mTc-labeled anti-carcinoembryonic antigen antibodies: an intraindividual comparison.
Behr TM; Becker WS; Klein MW; Bair HJ; Scheele JR; Wolf FG
Cancer Res; 1995 Dec; 55(23 Suppl):5786s-5793s. PubMed ID: 7493347
[TBL] [Abstract][Full Text] [Related]
44. Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments.
Kenanova V; Olafsen T; Crow DM; Sundaresan G; Subbarayan M; Carter NH; Ikle DN; Yazaki PJ; Chatziioannou AF; Gambhir SS; Williams LE; Shively JE; Colcher D; Raubitschek AA; Wu AM
Cancer Res; 2005 Jan; 65(2):622-31. PubMed ID: 15695407
[TBL] [Abstract][Full Text] [Related]
45. Tumor targeting in vivo and metabolic fate of 5-[iodine-125]iodo-2'-deoxyuridine following intratumoral injection in patients with colorectal cancer.
Mariani G; Cei A; Collecchi P; Baranowska-Kortylewicz J; Van den Abbeele AD; Di Luca L; Di Stefano R; Viacava P; Ferdeghini EM; Di Sacco S
J Nucl Med; 1993 Jul; 34(7):1175-83. PubMed ID: 8315499
[TBL] [Abstract][Full Text] [Related]
46. SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery.
Gutowski M; Framery B; Boonstra MC; Garambois V; Quenet F; Dumas K; Scherninski F; Cailler F; Vahrmeijer AL; Pèlegrin A
Surg Oncol; 2017 Jun; 26(2):153-162. PubMed ID: 28577721
[TBL] [Abstract][Full Text] [Related]
47. Feasibility of radioimmunoguided surgery of colorectal carcinoma using indium 111 CEA specific antibody and simulation with a phantom using 2 steps targetting with bispecific antibody.
Hamy A; Curtet C; Paineau J; Chatal JF; Visset J
Tumori; 1995; 81(3 Suppl):103-6. PubMed ID: 7571036
[TBL] [Abstract][Full Text] [Related]
48. Circulating antigen: bad or good for immunoscintigraphy?
Pimm MV
Nucl Med Biol; 1995 Feb; 22(2):137-45. PubMed ID: 7767306
[TBL] [Abstract][Full Text] [Related]
49. Heterogeneous distribution of radiolabelled monoclonal antibody. Autoradiographic evaluation in the nude rat model.
Ingvar C; Norrgren K; Strand SE; Jönsson PE
Anticancer Res; 1994; 14(1A):141-6. PubMed ID: 8166441
[TBL] [Abstract][Full Text] [Related]
50. [Diagnosis of local recurrence of colorectal cancer, using PET and immunoscintigraphy by means of 131I or 111In anti-CEA monoclonal antibody].
Ito K; Nakata K; Watanabe T; Hibi K; Kasai Y; Akiyama S; Takagi H
Nihon Geka Gakkai Zasshi; 1997 Mar; 98(3):373-9. PubMed ID: 9101544
[TBL] [Abstract][Full Text] [Related]
51. The comparative distribution of monoclonal antibodies to CEA in colorectal xenografts.
Lewis JC; Boxer GM; Searle F; Bagshawe KD
Tumour Biol; 1984; 5(5):255-61. PubMed ID: 6397841
[TBL] [Abstract][Full Text] [Related]
52. Experimental radioimmunoguided surgery for peritoneal metastases of gastric cancer using anticarcinoembryonic antigen-specific T84.66 F(ab')2.
Kim JC; Hong HK; Lee KH; Ka IH; Roh SA; Koo KH; Kim HC; Oh ST; Oh SJ; Kim JS; Park KC
J Cancer Res Clin Oncol; 2005 Aug; 131(8):495-503. PubMed ID: 15887029
[TBL] [Abstract][Full Text] [Related]
53. Rapid and specific targeting of monoclonal antibody A33 to a colon cancer xenograft in nude mice.
Barendswaard EC; Scott AM; Divgi CR; Williams C; Coplan K; Riedel E; Yao TJ; Gansow OA; Finn RD; Larson SM; Old LJ; Welt S
Int J Oncol; 1998 Jan; 12(1):45-53. PubMed ID: 9454885
[TBL] [Abstract][Full Text] [Related]
54. Surgery for colorectal cancer guided by radiodetecting probe. Clinical evaluation using monoclonal antibody B72.3.
Stella M; De Nardi P; Paganelli G; Sassi I; Zito M; Magnani P; Baratti D; Mangili F; Spagnolo W; Siccardi AG
Eur J Surg; 1991 Aug; 157(8):485-8. PubMed ID: 1681938
[TBL] [Abstract][Full Text] [Related]
55. 124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice.
Sundaresan G; Yazaki PJ; Shively JE; Finn RD; Larson SM; Raubitschek AA; Williams LE; Chatziioannou AF; Gambhir SS; Wu AM
J Nucl Med; 2003 Dec; 44(12):1962-9. PubMed ID: 14660722
[TBL] [Abstract][Full Text] [Related]
56. Radioimmunodetection of neuroblastoma cells with I-131-radiolabelled antibodies.
Voigt A; Berndt A; Lauterbach H; Carlsohn H; Hüller M; Stiller KJ; Gottschild D; Zintl F
Cancer Biother Radiopharm; 1997 Jun; 12(3):187-94. PubMed ID: 10851465
[TBL] [Abstract][Full Text] [Related]
57. Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab' fragments.
Casey JL; Pedley RB; King DJ; Green AJ; Yarranton GT; Begent RH
Br J Cancer; 1999 Nov; 81(6):972-80. PubMed ID: 10576653
[TBL] [Abstract][Full Text] [Related]
58. Clearance of circulating radio-antibodies using streptavidin or second antibodies in a xenograft model.
Marshall D; Pedley RB; Boden JA; Boden R; Begent RH
Br J Cancer; 1994 Mar; 69(3):502-7. PubMed ID: 8123481
[TBL] [Abstract][Full Text] [Related]
59. Diagnostic accuracy of 99mTc-anti-CEA immunoscintigraphy in patients with liver metastases from colorectal carcinoma.
Bock E; Becker W; Scheele J; Wolf F
Nuklearmedizin; 1992 Jun; 31(3):80-3. PubMed ID: 1641359
[TBL] [Abstract][Full Text] [Related]
60. Localisation of monoclonal antibodies reacting with different epitopes on carcinoembryonic antigen (CEA)--implications for targeted therapy.
Boxer GM; Abassi AM; Pedley RB; Begent RH
Br J Cancer; 1994 Feb; 69(2):307-14. PubMed ID: 7507692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
